Inhaled Corticosteroids for the Prevention of Bronchopulmonary Dysplasia and Complications of Prematurity
- 1 July 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 200 (1) , 98-100
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging studyBMC Pediatrics, 2018
- Long-Term Effects of Inhaled Budesonide for Bronchopulmonary DysplasiaNew England Journal of Medicine, 2018
- Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary OutcomesJournal of Clinical Medicine, 2017
- Inhaled hydrofluoalkane-beclomethasone dipropionate in bronchopulmonary dysplasia. A double-blind, randomized, controlled pilot studyJournal of Perinatology, 2016
- Early Inhaled Budesonide for the Prevention of Bronchopulmonary DysplasiaNew England Journal of Medicine, 2015
- Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012JAMA, 2015
- Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary DysplasiaPLOS ONE, 2014
- Association of a quality improvement program with neonatal outcomes in extremely preterm infants: a prospective cohort studyCanadian Medical Association Journal, 2014
- The new bronchopulmonary dysplasiaCurrent Opinion in Pediatrics, 2011
- Extra-Fine Particles Improve Lung Delivery of Inhaled Steroids in InfantsaChest, 2003